Wessex Cancer Support Annual Report and Accounts 2023 essex Cancer Support Registered Charity Number 01110216 Registered Company Number 05416311 IA company limited by guarantee) Wessex Canw Support Annual report and accounts for the year ended 31 December 2023 Contents page Legal and admlnlstratlve information Year in review Report of the Trustees Independent auditor's report 24 Consolidated statement of financial activities 28 Consolidated and Charity balan￿ sheets 30 Consolidated ststernent of cash flows 31 Notes to the financial statements 32 Wtssex QKer 9JpkKJrt. Reglstwed Company No.. 05416311 Page 2 of 47 Wessex Cancer Support AnNal report and accounts for the year ended 31 December 2023 Legal and administrative information Charity Name Wesse¥ Can￿r SuptX)rt (fomerly Wessex Cancer Trust) Company Number 05416311 Charity Register￿ Numter 01110216 RegTstered Offi 91-95 Winthester Road Chandlerfs Ford Eastleigh, S053 2GG The direttors of the charitable ccthpany are its trustees for the puryjoses of charity law. The trustees and offi￿rS serving during the year and SIn￿ the year end We￿ as follow5: Board of trustees Mrs D Cutler Mr M Miles FCA Mr J Plumtree FCA Dr E Arden-close Mr J Clough Mr T Jones FCA Chair TreasU￿r Vlce Chair Mrs R C Brockwdl Mrs E Galambos Mrs G McKnight Appointed 6 July 2023 Appointed 3 August 2023 Appointed 2 January 2024 Ms S Bedells Resigned 4 May 2023 Secretary Mr D Robertson CA(SA) Chief Executive Rachel Billsbeny-GrdSS Legal Advi5CfS Parls Smith LLP London Road Southampton, 5015 2AE Auditors Azets Audit Services Athenia House, 10-14 Andover Road Winthester Hampshire, S023 7BS Investment AdvlscKs Sarasin & Pathers Juxon House, 100 St Paul's Churchyard London EC4M 8BU we￿ Cancer Sup[￿- Re9iSterex1 CNnp3ny No.. 0￿16311 Pa9e 3 of47 We55ex Canw Support Annual report and accounts for the year ended 31 Dètémber 2023 Bankers The Royal Bank of Scrtland 56 High Street Southampton, 5014 2NP Co-Operat(ve Bank PO Box 250, Delf H¢￿se Skelmersdale, WN8 6 We*x CarKtr Support. Reg&ered c￿M￿Y No.. 05416311 Page 4 of47 Wessex Cancer Support Annual report and accounts for the yéar ended 31 De￿mber 2023 Year in Review A message from our Chair Reflecting on the past year, I am heartened by the progress that has been made towards our vision of a future where everyone in Wessex has access to personalised 5UPPOrt that empowers them to live well with and beyond Can￿r. I would pe￿OnallY like to extend my sin￿re gratitude to all the donors, volunteers, and stsff whose dedication has tEen instrumental in our achievements. Our servi￿5 focus on the emotional health and wellbeing of anyone affected by cancer, whether It Is the person Ilvlng with cantrr themselves, or their loved ones. Th￿Ugh our thrtryear Can￿r Support for All strategy launched In 2022, we aim to double our reach and eXt￿d our ￿Ni￿S to individuals and comrnunities that dont curmtly access a serviTr like ours. I have been encouraged to see a marked Increase in the number of individuals accessing our servi￿$ during 2023 and the overwhelmingly p)sitive client feedback confimis the irnportan￿ and impart of our work in the community. The majority of our clients have been supported through one of our four cancer support ￿ntre$. There, dients can access personalised holistic support which can include tefriending, counselling and complementsry thernpies as well as gentle exerase classes. In 2023 we launched our new digitsl outreach prc4Jramme, an essential step towards extending our seNices to new communities. The aim of the progrBmme is to replicate as closely as Fossible, the Servi￿ a dient can access at a support ￿ntre, via a dedicated online Fortal. While the uptske of digiL31 Servi￿ has been gradual, we remain committed to enhancing accessibility and inclusivity in our services, and aLTOSS the charity. Partnership5 with other charitie5, the NHS and other healthcare prowders have and will continue to be importsnt to us. By collaborating with stakehoiders a¢YOSS the region, we can ensure our serVi￿S remaln relevant to meet l¢xal needs. The￿ is still much to be done; in the recent Cancer Patient EXperIen￿ Survey, 400h of people in the Wessex region felt that they did not receive enough care and SUPFK)rt from communty or voluntary seNi￿S. Agaln, this emphasises the vital need for our Servi￿5. During 2023 we have faced a n￿rnber of challenges induding increased costs, a competitive fundraising landscape, and recruitment difficulties, all exacerbated by the ongoing cost of living crisis. To help address these we have Invested in our Feople, intrtyjucing new welltrEing initiatives and growing our teams to better manage the increased workload acr055 all areas, We have also invested in our InLX)me generation capabilities and rollgj out a refreshed brand, with a new name that better refletts our work. Desprfce some of the challervjes during the year, we have remained ilient, thank5 to the generosity of our supporters. Our fundraising income and retsil sales, though impacted, have demonstrated the high regard in which we are held by the community. Looking ahead, we recDJnise the changing landscape of healtlKare, with advan￿rnents in Al and an increasingly strained NHS. Our emotional and wdlbeing SUPFX)rt Sery￿e$ will be more vital than ever In an era of less petsonal treatsnent. As we develop our strategy for the five years from 2025, remain fc(used on our mission to help improve the eMo￿onal health and wellbeing of anyone affectsj by ￿n￿r. We5sax Canor Support. Reglstued Ccfflpany No.. 05416311 Page 5 of 47 Wessex Cancer support Annual report and accounts for the year Ènded 31 December 2023 I would like to extend my heartfelt thanks to you for being part of Wessex Can￿r Supwrt's Journey in 2023. Warm regards, Diane Cutler, Chair of Trustees •• Wessex Ca￿er Support. Regi*er¢d Company No.. 05416311 Pèje 6 c147 Wessex Cancer Support Annual report and accounts for the year ended 31 December 2023 A message from the CEO I'm delighted to share our annual report with you. This was the middle year of our three year Can￿r SuppDrt for All strategy and we have ￿en encouraged by the tangible prcoress that has been made towards our strategic goals. There is no doubt that Wessex Can￿r Support is becoming a more imw)rtant Vol￿ in the can￿r support landscape in the region. In 2023 1,836 people used our Servi￿5, a third more than in 2022. We are well on our way to athieving our strateglc aim of doubling the numter of dients we SUp￿rt in a year, by the end of 2024. This has been achieved without sacrifiang the quality of the SeN1￿ we deliver. That 98% of our dients rat&J the supp¢)rt they received as being ¢)XMJ or Ex￿lIent, makes me enomously proud for all the staff and volunteers that contribute in so many ways, to our charity. When reviewing the year, there are a few highlights in addition to these strong results for our Servi￿$. The launch of a new digital seNitr which is designed to mirnr as dosely as pssible, the personall￿1 approach that wr ￿ntre5 are known for. This new se￿1￿ has meant that we can expand our reach to parts of the region where there is little Izncer supwrt, and target communities who are less likely to u* servi￿5 that are delivered through a ￿ntre, The sUc￿Sful implementation of a refreshed brand that has teen greeted with enthusiasm from our stskeholders. Our change of name to Wes*x Can￿r Support refl￿S the nature of our work more clearlyi ensuring that more people will understand that our serVi￿S are for them. In order to save C￿ costs it has tsken several months to roll out the new materials, but we expect thls to be cc%nplete by the middle of 2024. Further growth in partnership wothngi with enhanced relationships with other charities, Wessex Can￿r Alliance, the NHS, I￿al community groups, companies and cancer 5UPPOrt workers throughout the regicrf). This has led to more opportunity for us to effectively provide our high quality suppjrt to more people affected by cantrr. Investment in staff and volunteers, with a focus on wellbeing at work, and new values and behaviours which *t the standards for how we hold ourselves to account, Seeing the energy and enthuslasm in our fundraising and retsil activities, whith has meant that despite a challenging year, we have seen some green 5hcots of growth in some of our income stream5. I'm grateful to all the people we've worked with over the past year - the dedicated supporters, Trustees and volunteers,, the organisations wetre partnered wf(h in servitrs and fundraising; and our hard-working, generous and supportive colleagues. l also want to say an erK)rmous thank you to all the clients who have trusted us when they are at their most vulneratAe. We finish the year feeling encourag&d by the tsn9ible results of our strategic plan that have come to fruition during 2023. These have enabled us to support many more people with (2ncer. In 2024, the final year of our current strategyi we intend to embed the progre55 we've achleved, while planning our priorities for our next five years. This Includes the recognltion that our core income must grow substantially to meet the cost of deliwing our seNices and the growth in client nUm￿rs, a task that we approach with a sense of seriousness and determination. Building this sustainable income will tske time, but our robust financial management and generous legaq donations have sitioned us wlth strong reserves to support this period of gwth. Wessex Carn￿r Sup￿t- Registered Conbpany No,. 05416311 d9e7of4? Wessex Cancer Support Annual report and accounts for the year ended 31 December 2023 There are still thousands of people in the region who simply do not get the SUPPK)rt they need to cope th the impart of cancer. They might experience feelings of isolation, sadness and depression, or being oveMhelmed, fedlngs that ￿n impact on all areas of their lives. We aim to be there for them. The solid foundations we have laid will enable us to m*t this challenge in the comiro years. With the SUPF()rt of our donor5, fundraisers, customers, volunt&rs and staff we o4n continue to make a meaningful difference for F*e with can￿r and their loved one5. Rad)el Bil1sl￿ry-Grass, Chief Executwe we5*K Canw Sup[￿. Re￿ere￿ Cryany No,, 05416311 Pag? 8 of47 Wessex Cancer Support Annual report and accounts for the year ended 31 December 2023 Report of the trustees The trust￿5 present their rep￿ and the audited financial ststements for the twdve months end8J 31 DeCeM￿r 2023. The finanoal statement has teen prepared in accordan￿ with accounting poliaes set out on page 32 and cLxnply with the charitys memorandum and articles of aS￿lation, last amended on 19 july 2023, appli(3ble law and the requirements of the Ststement of Reo)mmended Practice Accr)unting and Reporting by Charities, Charities SORP (FRS102). Vision and Mission Vision Our vision is a future where everyone in Wessex has access to personalised SUp￿rt that empowers them to live well with and Wond cancer. Mission Our misslon Is to engage with l¢xal communities to help improve the emotional health and wellbeing of anyone affetted by Can￿r. Our work and impact in 2023 Wessex Can￿r SupFQrt servrces are oFen to people at any stage and with any type of cantrr, and their loved ones, to help improve their emotional health and wellbelng. We aim to offer a sUPPOrtive community and personalised ServI￿S that dlents can aC￿$S as they need. SeNices include counselllng, complementary therapies, befriending, movement and exercise sesslons and theraFe￿t￿ ch￿[S. these are deliverej toth indivKlually and in group settings. 'I have been suffering from severe stress and anxiety since my diagnosis but every time I come into the centre, l always leave f￿}ing a mi//ion times In our current strategy Cancer Supwrt for All (2022-24) we set ourselve5 four strategic priorities. This section outlines progress against each of those wiorities. Strategic priority I: More people will access our services Durlng 2023 we saw client numbers tske a sizeable leap to 1,836 {2022: 1,206) and we dellvered a record numter of support interactions at 16,500. Cancer support centres The majorlty of clients accessed support in one of our r￿n￿r support ￿ntres. As well as an increase in post-pandemic confiden￿, we attribute this growth in num￿e￿ to the efforts of our ￿ntre managers and marketing team, who have been steadity w0￿1ng to raise the profile of ServI￿S wlth both health professionals and the general public. Another factor is the growth and variety of servi￿5 offered in each ￿ntre, While there are core serv1￿5 that are delivered across all s￿e5, on a local level we evolve and adapt to meet the needs of wesiei C4Ker Support- Reg1stefftd Ctynwy No.. 054I63LI e9*￿47 Wessex Cancer Support Annual report and accounts for the year ajded 31 December 2023 the local community. For example, in 2023 Tai Chi returned to Chandler's Ford ats a four year gap, and a new ycrfja session w05 intrLK1U￿d in Boumemuth. In addition to the standard four day opening of each Trntre, the last year also saw trials of monthly or b1-W￿klY latw otRning times or evening sessions targeting particular groups. These includ￿1 a group for Ca￿rS In the Isle of Wight, a general support group in Bournemouth, and separate men's and women's evening support groups in Hythe. As dEnt numbers have grown, so too has we55ure capacity and this has resulted In waiting lists for some of our servi￿, primarily counsellin9. We utilise sessional worker5 to try to manage the ebbs and fkjws of demand, and with an approach that is rooted in agility and prDblem-solving, we have managed to minimise waiting times to a maximum of 12 W￿ks. During the waiting period, dients are encouraged to engage in other services such as drop-in IRfriending sessions. In Boumemouth, we invested in resource to trlal opening for an additional day each W￿k. this has been well and ha5 also helFed to ease wa￿Ing lists. Our aim to develop plans to mve the Bournemouth ￿nt￿ tcs a more permanent tr￿Me has not progressed due to stafflng resour￿. Although Spa￿ Is a bit limited, our current ￿ntre, which is within a modem shared Offi￿ building, works acceptably for our needs and is available on an ongoing basis. With new stsffing resourtr in pla￿, we expect to progress our plans for a move during 2024. The growth in numbers has also put pressure ¢Jn ￿ntre managers and their volunteer teams and during 2023 we tcok the decision to recruit to a new role of part-time ￿ntre co-ordinator for each Ic(ation. These new wsitions were filled quIc￿Y and are proving to be an imFQrtant support for ￿ntre managers. A breakdown of our services in2023 bEtn*n¢iinB- 28¥ . Vhei2•Y-26 s¥patVcOn￿WNtywp-I3￿ • GeDeral s￿￿clI. . PtyycalAcobty. g WElbringappt- In addition, there were 12,300 indThiidual journeys on the Da15y buses and 4,124 attendances at our Sing for Life choir5, as detailed further below. Outreach services During 2023 we further developed our communlty Outreach work, to meet our aim of reaching more Feople. Our fccus during the Ilfe of the strategyi Is to reach people in new geographical areas, namely Andover, Dorchester, Weymouth, Portsmouth and Portland; and deMographi￿1lY we aim to increase our engagement with men and people INing in areas of multlple deprivation. Our initial outreach pilot Servi￿ was launched in Andover in 2022 and we experted to open more, slmilar Servi￿ in 2023, Following evaluation of that first pilot in Andover, we adapted our approach. Wessex can￿ RegTstered Company No.. 05416311 Page 10 of47 Wessex Cancer Swpport Annual report and accounts for the year ended 31 December 2023 During 2023 we have f￿USed on developing and building a strong digital support switr which we anticipate will tetter enable u5 to readi new and different communities. Due to the continue(I ￿rUItMent challenges across the board in 2023, we were unable to fill the newty created position of digital Servi￿ manager, a key objective. Instead we engaged a highly skilled freelan￿r, expediting the development of the digitsl service, which was then ready for launch at the end of July 2023. Having little or no profile or reputation in the tsrgeted regions, it proved difficu5t to gain traction. By the end of the year our focus had shifted towards promoting the servi in the wider region reSu￿1ng in some online engagement. Although recruiting new clients to (yjr online Sery1￿ has presented ￿rrE djall￿ge$, we have ontinued to deliver various wvices online. These have included a sound therapy group, a bi-weekly men's supkx)rt group run in partnership with AFC Bournemouth, and sorne one40-one a)unselling sessions. We also host a thriving Fa￿book 5UPPOrt group with over 300 memt￿rS. Support interactions broken down by in-personvs onlinelremotedelivery PlryslcalAttivity Welkneln8 appt 1000 2￿0 2￿0 3￿0 •lfvperson liemffj• We know from feedbad( that being able to access a blended provision of both online and in person seryices is impK)rtant to dients, and so our efforts will continue in 2024 as we strive to further grow the user base. Daisy Buses Our two Dalsy Buses in *)uthampton and Potsmouth, continued to offer a vital se￿1￿ for patients travelling from the Isle of Wight for treatment on the mainland. The seNio is also provided to patients from Jersey under a contratt with the States of Jersey Govemment and with the support of our long- temi partner, Jersey Cantrr Trust. During the year we delivered a total of 12,300 indlvidual Daisy bus joumeys (2022: 11,500). Sing for Life Choirs Wessex Can￿r Supwrt servi￿5 are rooted in Itxal communities and this is particularfy the case with our Slng for Life choir5. Slnging can help lower stress, bLK)st immunity and lung functM)n and improve mentsl health, and our infom)al singing groups offer a SUPFQrtive community that benefit many Wessex Canw s￿p￿t. Reglltt￿d CL*Trpany No.. 05416311 Page 11 of 47 Wessex Cancer Support Annual report and accounts for the year ended 31 December 2023 people affected by Car￿r. For the Salisbury choir, 2023 was a landmark year, celebrBting its 10th anniversary with a wonderful cOn￿rt in Salisbury Medieval Hall in June. The choir has now expanded to 80 rajular members; to manage this we will be intrc¥Judng addltional choir medings during 2024. Our Isle of Wight ctboir, established in 2022, grew steadily dunng the year, while our more established thoirs in Totton and Cosham (xintinued to thrive. The choirs underto)k several public perf0mlan￿, •• including at Romsey Festival and at our own fundraising Christmas Carol COn￿rt in ritchf￿1d. CommLJnications and Marketing In 2023 we began the roll out of our new refreshed brand, which has included a thange of name to Wessex Cancer SupFQrt. This aim5 to more deady a￿'cUlate who we are and what we do, and te welwming to people from the diverse communities and demc*Jraphits in the region. •• To effectively manage expenditure arxl workload this hapFened gradually ¢)ver an extended Feriod, with the refreshed brand king intrixluced as existing stocks ran down. Full adoption of the refreshed brand across all collateral including clothing, signage and shop fronts, will continue during the early part of 2024. (Photo below Is the shop front of our new WestLx>urne shcp OFened in March 2024.) lili Wessex Cancer Support Til The increase In client numbers 15 testament to Improved brand management and a renewgj focus on profile raising activ￿leS across the organisation. We are continuing to build our reputation with regional media. This was eVIden￿d in recent coverage of the cancer diagn05e5 of both the King and the Prin￿55 of Wales, when we were approached for interviews and comments. The trustees recognise that strong communications and marketing for the charity is a key driver of growth and this will te an area of investment in future years. Strategic priority 2: Our clients will receive high quality personalised support Everyone's eXperIen￿ of can￿r is highty individual and there is no right or wrong way to f*1, respond or behave. This is a ￿ntral tenet of our serv1￿, and we aim to offer support that is personallsed to the client. Wesw Canryr Supwrt. RvJi*¥ed Ctyr4)any No., C6416311 Page X2 ￿47 Wessex Gincer Support Annual rep¢)rt and accounts for the year ended 31 December 2023 Anyone can self-refer to Wessex Can￿r Support, and new dients are ¢lfered an inib'al appoinbnent with our wellbelng c(￿OrdInatOr to discuss what SUPFQrt they might need. The output is a personalised support plan which coukl indude a prcoramme of one or more services gjch as bi-weekjy Reiki sessions and a weekly supwrt group. At the end of the iniknal support programme (usually around 6 months later), each dient 15 offered a follow up m&ting with the wellLEing co-ordinator to dlscuss whether any ongoing sUPP)rt is needed. Monitoring and evaluation During 2023 we have further improved our ability to capture f￿back and anatyse dats to ensu￿ we are successfully monitoring and evaluating services. Information about how clients are feeling and coping is coll&ted during their inftial wellbeing a55essment, and this is used as a trEnchmark to monitor and evaluate prcoress. In 2023 we also intrcXJu￿d the use of QR coded feedback links, whith are displayed in ￿ntreS to encourage dients to give us their view. We are pleased to report that during the year 98% of dients rated the SUFWrt they had received as Gcrf)d or Extrllent. strategic priority 3: We will seek out meaningful strategic partnerships Wessex Cantrr SupFK>rt ServI￿S are a vitsl part of the local ￿n￿r provision. Since the charity was founded, we have worked with partner5 induding the NHS and other charities to provide suppjrt Servi￿ that complement can￿r *rY￿eS offered elsewhere. Partnership wod(ing is a continuej prh)rity, and in 2023 we strengthened relationships both at region-wide and communlty level to better influence the local cancer agenda and advocats for our clients, We work with the Wessex Can￿r Allian￿ (WCA) and IcKal can￿r servi￿, and our CEO and Director of servi￿ represent the charfty on key l>)ards and working groupst including WCA'S Personalised Care Prc>JrBmme Board. Through our relationship with WCK we have been invlted to partner on pro]￿ which have enabled us to ernbra￿ opportuntties to enhan￿ our accessibility more broadty. This includes partiapation in the Whatever it Takes project which Is being led by charity Help and Care and funded by NIHCR and is specifically aimed at understanding the needs of transgender people affected by Can￿r. In 2023 we were contratted to deliver some counselling and therapy seNlces on site at Southampton General, QA hospitsl Portsmouth and the Royal Bournemouth hospital. We also renewed the long- standing contrart with Ststes of Jew to provide patient transport from local hotels to Somjthampton and Portsmouth. We have also explored opportunltSes with commeraal organi5ations wothng in the same field and towards the end of 2023 agre&J a worklng partnership with Harbour Hospitsls in Poole, wlth the aim of shartng best prattitr and some resour￿ to improve 5UPPOrt for people with [￿n￿r. Strategic priority 4: Our charity will be financially stablei operate efficiently and attract and retain high quality staff and volunteers. During 2023 we maintslned financial stsbillty through dose management of resour￿ and a focus on our voluntary income streams. Wessex Cancer gJrnrt. R*J*ered Company No.. OY16311 P*Je 13 Qf 47 Wessex Cancer Support ADnual report and accounts for the year ended 31 December 2023 Legacies and Fundraising Income from legacies was healthy in 2023 and this conunues to be a vitslty imwrtant 9)Ur￿ of income for the charity. The trustees offer our sin￿re gratitude to everycffle who chc¥)ses to donats to Wessex Cancer Support by leaving a gift in their will of whatever size, We are fortunate to have a skn'lled volunteer ovetseeing our legacy administration. Her role involves liaising with solidtors to ensure the smooth prccessing of legacy pledges, minimising delays and bJreaucTatic hurdles for the charity and we are very grateful to have this suprK)rt. In other fundraising income streams, there was continued Un￿rtaInty ¥thich meant that growth in mst areas was sbwer than targeted. In part this 15 due to several external factors, in particular the difficult market for recruiting and retaining stsff and the general level of economic Un￿rtaInty brought on by the cost of living crisis and ge￿polItiCal situation. This has resulted in vacancies during the year, and necessary time spent indutting and setuing new memtells of staff. Two of the* new roles were a head of philanthropy and a fundraising prospect researcher. These were strategic ap￿intrnents, fccusing on expandlng and cultivating our larger grant, donation and partnership income streams from major donors, trusts and companles. Establishing robust connections with both current and potential SUPFOrters will LE cruaal to our success in this area. In 2023 we also recruited a database administratcf, another new role. This F4)sition overs*s our fundraising databa￿, and is focused on improving our uts'lisation and analysis of dats to further our fundraising objectives. Our other fundraising income streams have remained reasonably steady compared to the previous year. With marginal growth in some areas, there is reason to feel optimistic that future expansion is FQ5sible. Among the high1￿hts of the year, was a sizeable cortK)rate donation which was facilitst&l by an introdurtion from of our clients. This highlights the value and impact of etvjorsements and introdudions from dients atKI c*her friends of the charity, and thi5 15 an area that we will be focusing on further in the future, We were a150 pleased to see that In￿Me from community and events fundraising increased on the previous year. Thi5 has been the mainstsy of Wessex Can￿r Supporfs fundraising in the past, and it Is encouraging to see this growth. Of note was our quiz night hosted by HLwJh Dennis, which attracted over 40 teams and our ever-twular Christmas carol contrrt which returnèj wlth guest speakers Martin Clunes, Alan Tltchmarsh and Sam Fraser and included a Performan￿ from our Slng for Life d)oir. Our biggest fundraising event of the year was the Swim for Hope from Hurst Point near Lymington to Colwell Bay on the Isle of Wight. This year saw 50 intrepid swimmers taking on the d)allenge and raisiw almost £60,000. Retail Our five retsil shops performed well during 2023, achieving a M￿lest uplift in Sales. Thls Is the result of a focus on marglnal gains across all c￿r shops, with a reswnsive appn)ach to pricing and sales promotions. Inevitsbly h¢)wever, gains in income were offset by a parallel increase in costs. Thls was primarily seen in staffing o)sts, with a notsb1e uplift in the National Living Wage Impatt4ng on our core costs. Overall contribution to the tharity was therefore down by around 200/0. In 2023 we set an ambttious goal of achieving 50Wo Gift Aid rate, but due to dela￿ in the implementatlon of our digitsl Gift system, we achieved 34% (2022: 380h). on￿ the system was OFerab'onal, we began to see Incrementsl improvements in this area, so we are confident of growth in 2024. Wwex Cancer Swwt. wsteffjd Company No.. 05416311 dge 14 of47 Wessex Cancer Support Annual report and accounts for the year ended 31 December 2023 The 5haps are an important part of the charity, providing txsth income and a hith street presen which helps raise the profile of our servi￿. In earfy 2024 we have opened another shop in Bournemouth and the early results show great promise. Wessex Can￿r Supwrt is reliant on voluntary income such as donatlons, gifts in a will, participation In fundraising acbvities, and $31e5 and donations of second-hand goods in our shops. Many, many individua15, organisations, dubs, schcK)Is and companies supported the charity during 2023 in a whole host of ways, and we are enormously grateful for that support. Our people One of the most significant risks to the charity is the ongoing challenges around recruiting and retaining staff. This is common across many sectors and in the voluntary sector this extends to volunteers as well as paid staff. At Wessex Cancer SuFp)rt we are reliant on volunt￿r5 to deliver our servI￿s, stsff our shops and 5UPPOrt fundraising. Volunteers are carefully vetted and trained and approximately 200 volunteers woth across the cM7Janisation with our workforce which is also Strengthened by paid sessional worker In reswnse to this challenge, we strengthened our senior leadership team in 2023 by recruiting to a new post of Director of Organisational Effectiveness. This role l)olds responsibility for all Feople- related matters, as well as ¢)verseeing monitoring and evaluation prO￿Se$ and spearheading PrO￿em￿oIvIng initiatives organisation-wide, to enhance our project delivery. The rx)st was fillej internally by Colette Cowan who has worked as Director of seNi￿s for over fwe years. In early 2024, Suzanne Bannister joined the charity to lead SeNiw, bringing a wealth of experientr in the voluntary sector and the NHSI particularly in cancer support se￿iceS For the first time in many years, in 2023 we held a full staff aThJ volunteer away day which was attended by the majority of paid staff and approximately a quarter of volunteers, over 94% of attendees rated the day as go￿1 or eX￿lIent. staff and volunteers are also regularty er￿Ur&Jed to offer swJgestions and provmle any other feedback both in person and through regular surveys. At Wessex Can￿r Support we Okvate a flexible working environment. Paid 5tsff have the benefit of a comprehenswe employee assistsn￿ programme which offers physical and mental health suprort. During 2023 we also introduced a wdlbeing at work group which involves stsff from across the organi5ation. We reccgnise the importantr of training for t>)th staff and volunteers, and have an in-house t￿[nIng resource whith covers a number of core subjerts including safeguarding and listening sknlls. In 2023 we ajntinued to invest in this area, with a prcoramme of induttion and refresher trainingi as well as extemal tralning for members of stsff where needed. The trustees thank all the stsff and volunteets who have helped the charlty to achieve tremendous results for people with can￿r and their loved ones during 2023. We particularfy recognise the stsff, volunteers and sessional worker5 who deliver our Se￿1￿5,. every day, they offer support to individuals who are navigating the most difficult time. Such work is undeniably demanding emotionally, and we extend our heartfelt gratitude to each of them. Equity, diversity and inclusion At Wessex Can￿r Support we are committed to equalty, dIVe￿ity and inclusion (EDI) and during 2023 v¥e have continu& to implement our EDI strategy. Wessex Canw Supwrt. RegLoered Company t40.. OS4L6311 Page 15 of47 Wessex Cancer Support Annual report and accounts for the year ended 31 December 2023 Durlng 2023 we have established an internal EDI trskfOr￿ with members from acro￿ the charity. The group is resFonslble for rnonitoring our work and advising where improvements could be made to improve diversity. Other measures include for eXaM￿e reviewing the language imagery used in our marketing collaterdl. We have s￿n some impact of this work wlth 4.5% improvement in overall diversity of our dients. In the workforce as a whole there is moderate diversity. Of particular note: the number of people in our Workfor￿ who have a disability, and the number who identify as having a LGwf+ orientation, are around double the estimated naknonal average in tx)th areas. We are a150 working to improve Board diversity and skills. There is an equal male I female split and people with lived experien￿ of can￿r. During the year the Board was strengthened with the additions of Rebecca (Becks) Brockwell and Edit Galambos. Becks is founder of a digitsl marketing agency and has brought a new perspective to the Board. Edit is a lead cancer nurse at the QA in Portsmouth and brings her expertise in can￿r Servi￿ within the NHS. In early 2024, we also recruited Gemma McKnight; as an eXp*rien￿d fundftiser, she brings a new sklll to the Board. EDI will remain an area of focus for the Board in the next year and teyond. Plans for future periods During 2024, which is the final year of our 2022-2024 strategic plan Can￿r Supwrt for All, we will contlnue to strive to reach our four key strateglc priorities, and SFecifically: Develop and publish our new 5-year strateglc plan for 2025-2030, consults'ng and involving stskeholders. Build, monitor and evaluate uptake of our dlgitsl support servtis. Use benthmarking to build and grow our brand profile In the region. Diversify our fundraising activity, developing a reliable plpellne of opportunitEs worth £IOk+. Undertake an organisation-wide review of salaries, benefits and welltelng initiatives. Develop ar)d implement a plan to find a future pemianent home for our Boumemouth ￿n￿r support ￿ntre. Rollout the work of our equity, dwersity and induslon t3skfor￿ to ensure we are engaging with and meeting the needs of people across all areas of the region. Financial review The Group's totsl income in 2023 was £1,912,459 (2022.. £2,543,018), The end of year outcome was a defiat of £36,948 (2022: Surplus £832,746). This year on year decline was antiopated and is mainly attributed to a reduCtiC￿ in legaq income received in 2023, following a notably strong prior year. The net deficit wsition was further impacted by investment in our service5 and to grow future Inccffle, together with the effects of the cost inflationary environment in whlch we opernte. Income In 2023, we enjoyed a year of strong legacy donatlons with income of £562,934 (2022.. £827,054). In another challenging year for fundraising, this was a tremendous kcost. This is an unreliable income stream and while income has teen strong in this area Sin￿ 2021, the trustees are mindful that growth in other income streams is cribcal if we are to athieve a rnore Wessex CanLtr Supwjrt . Rewred c￿lp3nY t40.. 05416311 Pa9e 16 ¢f47 Wessex Canw Support Annual report and accounts for the year ended 31 December 2023 Sustainable future for the charity, The staffing d)allenges of 2023 were fdt m05t acutely in fundraising and we saw the impact of thls across all fundraising Income streams with slower growth than tsnJeted. We also saw (L)ntinued keen competition for funding, the effect of the cost of living crisis and the general level of eLDnomic uncertAinty. As a result of these challenges, we saw a year C￿ year decrease in totsl fundraising income, at £735,218 (2022: £848,188). However, there was some marginal bjt encouraging growth in events, community and corwrate fundraising. Fundraising makes up the lar￿ proportion of our annual income and the trustees remain Steadfast in our commitment to investing for future growth and sustsinability. The Group's income also includes retail tradlng, urmdertaken through a wholly owned subsidiary, Wessex Can￿r Support Trading Limited. Throwh our outlets in Weeke in Winthester, thandlerfs Ford, Freshwater on the Isle of Wight, Hythe and Portche5ter, we adiieved overall income of £567,468 (2022.. £530,759). Proflt after tsxation was £101,895 (2022: £127,145). While the incrementsl uplift in ￿leS income on the prevlous year is encouraging, thi5 was necessary to balance the incTeased expenditure that we saw in retail during the year. During 2023 the Board app￿)Ved a plan to open a sixth shop in the Bournemouth area. After comprehensive search, we identified a suitable shop in Westboume, which was opened SUc￿s1u11Y in earfy 2024. The majority of our income, ccffles from the generosity of our supporters. Whether through finanaal donations, gifts in a will, participation in fundraising events, or by donating or buying second-hand goods in our shops, our supporters play a crucial mle in sustaining the charity. We extend our heartfelt thanks to all those individuals, organisations, clubs, schools and companies that suppx)rtgJ Wessex Can￿r Support during 2023. Expenditure FundrBi5ing costs were £326,561 (2022: £286,800), with the increase attributsble to additional staff costs. During the year we expanded our fundraising team by recruiting three new roles In fundraising., a head of philanthropy, a fundraising prospect researcher and a database administrator. These roles signify our commitment to investing in income streams that the trustees have identified as strBtoJlc priorities. In our retail dNision, costs were £463,096 (2022: £404,154). There was a 5igniflo3nt upward shift in salaries across retail in response to the 9.50/0 increase in National Living Wage (NLW). We also recruited to a new role of area manager to support and deputise for the retsil director. During the year we also made capital investment in the Implementstion of a new digitsl gift ald systEYn. Expenditure on Servi￿ rose to £1,218,839 (2022: £1,017,657). This can be partly attributed to an uplift in salary a￿5 and other overheads as well as new investment in developing and promoting our digitsl outreach se￿1￿. The increase in expenditure also reflerts greater usage of our seNI￿S during 2023, which required higher exFenditure on sessional staff as well as the recruitment of new tk3rt- time centre (J)-ordinators, Going Concern Throughout 2023 the charity has conb'nued to dosely monitor finan￿S and maintsin an 18-24 month cashflow forecast. We remain committed to the robust evaluation of income generation activities, Wessex CaTh*r Swport- Reglstered CompBny No.. 05416311 Page 17 of47 Wessex Cancer Support Annual report and accounts for the year ended 31 December 2023 cost saving measures and strategic investment, that will enable us to build a more sustalnable fjJture for the charity. Based on all available information the trustees have a reasonable exFeCtation that the charity wlll be able to continue in operation and meet its liabilities a5 they fall due for the foreseeable future, being a period of at least one year from the date of this rewrt. Therefore, the d￿rity continues to adopt the going con￿rn basis of accounting. Reserves Policy Free resetves are funds that are readily realisable and exdude funds whose use is restrlcted or designated for a particular purp￿. It a150 exclLKles investments, and funds invested in fixed a55ets utilised in the day to day running of the charity. In 2023 the trustee5 reviewed the appropriate level of free resetves needed by the d)arity and agreed a level of £0.9m - £1.3m, representing approximately 6 - 9 month5 of budgeted costs. Group free reseThes at year end date were within thi5 range at £1,223,776 {2022'. £1,183,721). The trustees also reviewed designat8J reserves and agreed a continued level of £1,200,(￿. The charity is heavily reliant on legacy Income whith is highly unpredittable. The appllcation of these designated reseNes over the medium term will enable the charity to develop, improve and expand its reach and range of services without reliance on this Un￿rtain income stream. This is reviewed by the trustees as part of the 5trntegic planning pr¢xess. During 2023, the trustees utilised £137,836 of designated reserves to cover the shortfall in fijndraised income. An equivalent amount of £137,836 (2022: £590,563) was set aside from unrestricted legacy income reoived during 2023, to maintain designated funds at £1,200,000. Totsl reseNes induding free and designated reserves were £3,006,849 (2022: £3,043,797) of whith £300,902 were restricted (2022: £652,091) and not available for general purFoses. Investment policy and performance The trustees have committed to investing funds in a resFK)nsible manner and for the investment portfolio to be managed in accordan￿ wlth the charity's charitsble mission and values and wlth regard to best practi￿ in environmental, sffial and governan￿ issues. Consistent with other medical research and support charities, the trustees have a fo￿￿1 exdusion on investment in tobacco (definej as a company deriving more than IOO/o of turnover from the manufacture of tobacco or tobacco related products). The Finaft￿ and Audit Commlttee reviews the allocation of assets regularly* tsking into account liquidity requirements and Investment characteristics of relevant asset classes and investment funds. The Committ& is responsible for oversight of the ￿rfOrman￿ of our investments, Our finan￿ team manages cash balan￿5 necessary to meet day-trday OFerational requirements, These balan￿S are pla￿ with our retail banking partners, comblned with the ublisation of the CAF Flagstone cash deposit platform. The platform allows us to maximi5e retums through an appropriately diversified ￿￿rollo, with all funds placed with banks having a minimum Fftch credlt rating of 'A', and eath deposit protected by the Finanaal Se￿1￿ Compensation Scheme. In 2023 we also appointed Sarasin & Partners LLP to manage a portfolio of Invested funds, to protett the value our funds and athieve a longer-term retum. The trustees have developed an investment pollcy whith aims to balan￿ maximising investsnent returns against the risk and liquldity of the investments. We5￿ Can￿r Support- Reglthred CLMnpa)y ND: 05416311 Page 18 of47 Wessex Cancer Support Annual report and accounts for the year ended 31 December 2023 The Sardsin Investment wrtfolio has returned 4.5Wo Sin￿ our Initial Investment on 8 August 2023. Structure, Governance and Management Charity incorporation w￿SeX Cancer Trust was established as a wistered UnIn￿rry)rated charty (280133) under a Trust Deed date(13 March 1980. In January 2005, the board of trustees decided to incorrthte the charity. A new company, We55ex Gincer Trust, was incorwrated under the ComF4anies P£t 1985 on 6 April 2005 and entewl into the Central Register of Charitie5 on 27 June 21J05 with registered numter 01110216. The assets and liabilities of the unincorporated Trust were transferred to the Company c l October 2005 when it commenced attivlties. On 26 June 2023, the company passed a Special Resolution to change its name to Wessex Cantrr Supwrt, following which the Registrar of Companies issued a Certificate of Incorporation on Change of Name from Wessex Can￿r Trust to Wessex Can￿r SuppJrt, dated 12 July 2023. Charitable objects A can￿r diagnosis can be devastating. Wessex Can￿r Supwrt offers emotional and wellbeing suppjrt for Feople with can￿r and their loved ones, to help them cope with the impact of Can￿r. Our objects outlined In governing document are: For the public tEnefit to asslst in the treatment and care of persons affec￿1 by cancer, the provision of support, education and prattical advice, induding raising funds to; complement and Improve cantsr care services by SUPFOrting patients, families and carers; Pmwding education and information patients, families and professionals. promoting can￿r prevention; mainly throughout Wessex including Hampth1￿, Dorset, Wiltshire, the Isle of Wight and the Channel Islands. Public benefit The trust￿ confirm that they have compli&J with the requirements of the Charities Act 2011 (Including amendments introduced by the Charities Act 2022) to have due r￿ard to the Charity Commission's general guidance on public benefit. Wessex Can￿r Supporfs attivities all provide public benefits. This is demonstrated throughout this report. Charity structure and management The Board oJnvenes four times a year. Decision5 by the Board are made by SIM￿ majority with the Chair taking the deciding vote as needed. In ackjition to these meetings the trustees chair and attend three sub-committees which Include G0veman￿, Risk and HR; Finan￿ and Audit; and the Advisory Committee. These committees also meet four times a year (Advisory Committee meets per year), and as part of thelr remits they support the larger ￿ard meetings by focusing on key areas of orgènlsational risk, stfttegy and assurance, a5 well as reviewing F(dicies that wuire development or renewal. The trustees a150 attend an annual strategy day, and the vitr chair is involved in the management- led Strateglc ImplemenL4tion Group which meets monthly to monitor and evaluate progress against the strategic plan. Wesw Can￿r SupkXJrt- Regl&ergJ CNnwy Ntr. 05416311 PaJe19 of47 Wessox Cancer Support Annual report and accounts for the year ended 31 December 2023 Trust*s serve for a maximum of terms with each tern consisting of four years and new trustees are identified through an o￿n reuuitment prO￿S and elected based on integrity and specific experien￿ needed on the Board. The chair lead5 the induction pro￿$ with the ￿0, and new trustees receive a comprehensive induttion pack and briefing5 from staff. At 31 Decemtrer 2023, the Governlng Board comprised eight trus￿. who a150 fonn the memtership of the Company. During the year the Board was StTengthened with the apwinbnent of Iwo new trustees, bringing expertise in digital marketlng and diniol cancer ca￿, and one trustee steprEd down. Our Board of trustees continued to embra￿ the Charity Governan￿ C(xle and review the charities policy and practi￿ against it aligned to the Charity Commsssion guidelines. The trustees are resFonsible for 5etbng the strategic directton and poliaes of the charity. The trustees apFoint a chief executive who is responsible for the day-to-day operations of the tharlty, working alongside department directors to ddiver the thartys work. The directri￿ retxirt to the chief executive. Remuneration policy The Governance, Risk & Human Resou￿ Committee re￿mMend$ any annual cost of living increases in consideration of the Consumer Pri￿ Index. In 2023 Mem￿￿ of staff were given cost-of-living increase of 4% (2022.. 3% + one one-off payment of 2.5Wo UP to max of Élk). Any other salary in¢yeases are based on (Erf0Than￿ or adVan￿Ment, The committee acknvely ￿vIewS remuneration of senior staff alongside these cost-of-living increases and with ￿feren￿ to extemal benchmarking within the charity sector. Salaries for new roles are review&J against market rates for similar roles in the charity sector. The Board agreed a further rise of 30/0 at the start of January 2024. A number of lower paid stsff received a greater increase to meet the National Living Wage which InC￿aSed in April 2024. the Board chose to IntrcdU￿ this change from the teginning of lanuary 2023. Management of ris The trustees have assessed the rnajor risks to which the charity is exposed and are satisfied that systems and pr￿U￿S are in pla￿ to mitigate our exposure. This assessment is reflected in a Risk Register which is regulatly reviewed by the Governan￿, Risk and HR Committee and the wtder Board. Mitigation plans are in pla￿ to reduTr, as far as wssible, the impact or likelih¢yxl of C£cUrren￿. The risks below are the ones of which the Boanl are particularly mindful.. Govemance and regulatory environment Insuffioent skills on andlor engagement by the Board leading to pC￿r deasion making andlor lack of oversight. Man8gement.'The composition of the Board is reviewed regulady to ensure that we have the right skills to fulfil our Governan￿ role. Trustees re￿1ve training. Lack of understsnding of public Folicy and Complian￿ with regulatory obligations. managern￿t.. Senior leadership team monitor public policy and the regulatory environment to ensure risks are managed, reporting to the Psjard. Wessex Carw &Jpptrt. Re9iSter&Y Company No: 05416311 dge 20 of47 Wessex Cancer Support Annual report and accounts for the year ended 31 December 2023 Adverse events Inchdents that damage repuiatKJn andlor negatively impart operations (indudingi fraud, supply chain di5ruptlon, major health and safety incidents, safeJuarding and internal prows failure5). Management.. We maintain a business continuty plan which is reviewed regularly. Regular financial reporting and monitoring. Proactive whistleblowing policy and media management. Monitoring of key suppliers, induding financial, and other due diligence check5. Regular reviews and training on all EX)licies and procedures, ind￿1ng safeguarding. Operational ris Computer system failures or adequacy of swems; loss of datsl data breach. Lryter serurity, Management.. During 2023 we achieved CyberEssentials accr&litstion and this has been renewed in early 2024. Cyber security is embLYlded in the charity with regular staff and volunteer training. Buslness continuity plan is regularly review￿. We use Microsoft 365 and have Outsour￿ our ￿ supFort. Poor vOlunt￿r recruttment and retentlonl lad( of volunteer comtEtencies. Managenwt." We have b)1stered the team wlth a new Director to lead on people Issues and work with our vOlunt￿r cwrdinator. We are g￿dUallY estsblishing a consistent approath across the charity and devekjping our Folicies, prttedures and tTrining to ensure good volunteer management. Hlgh staff tumover and recruitment challenges. Management.. In 2023 we have recTUited a new Director to lead on people issues. They will focus on reviews of HR practi￿$ and wellbeing initiatives. In addition, we offer flexible working nd annual salary awards. Regular staff appraisals with clear objectives. EDI strategy and monitoring. Regular feedback from emtAoyees and exit interviews with leavers. Financial Income, expenditure and cash flow. Msnagement.. Budgets set annually and m￿thlY monitoring of actuals to identify actions n*ded. Over-dependency on small number of income stream5. Management.. Fundraising strategy established and invesbnent in new areas to further diversify income streams. Designation of re*rves to help mitigate the risks of unpredictable legacy income. Investments presenting exposure to finarKial risk and market movements. Management.. Responsible investment approach with tsJard to best prattio In Environmentsl, Social and Governan￿ (ESG) issues, and in a￿ordan￿ with the chariVs own tharitable mission and values. Expert advi￿ infornis investment and treasury attlvities. Oversight of investment and treasury xtlvities by our Finan￿ & Audit Committee, who monltor complian and performantr. We5se¥ Concer Support. R￿￿tered Corn￿Y No.. 054163LI Page 21 of47 Wessex Cancer Support Annual report and accounts for the year ended 31 December 2023 Our approach to safeguarding In 2018 the Charity Commlssion underlined that tharities must te trusted places where people can feel safe. At Wessex Can￿r Support we have Safeguarding p)licie5 and prc￿dureS for Adults and Child￿n which reflect current legislat￿n stjch as The Mentsl Capacity Act 2005, Safeguarding Vulnerable Groups Art 2006 and the CAre Act 2014. The Multi-Agency Safeguarding Adults PoliLry and Guidan￿ (June 2020) developed by the Safeguarding Adults Boards in Hampshire, Southampton, Isle of Wight and Portsmouth, inform5 our training for stsff and volunteers. Our Director of Organisational Effectiveness is our Safeguarding Lead, supportej by the Director of SerV￿s who provides continueLI oversight and review of all safeguarding COn￿ms. The Govemantr, ￿"Sk and HR Committee receives regular UfKJates on safeguarding matters from the safeguarding lead, and reviews our safeguarding policy annually. Our approach to fundftising Wessex Can￿r SutW•rt is a member of the Fundraising Regulator and adheres to fundralsing cojes of practice. We employ a team of Fundraisers who work across the region. During 2023 we continued to develop a broader fundraising portfolio to mitigate the risks presented by an un￿rtain external environment. On occasion we use external agenaes to deliver fundraisirvj activrties, All activty is delwered to servi level agreements which are monitored through regular meetings, mystery shopping and r8Jular review of feedbad( and any complaints. Agenaes are contractually required to ensure all fundrdising attivity is in accordan￿ with all applicable legal requirements and the relevant binding code5 of practice issued by the Fundraising Regulator. Professional fundraising agencies must have dear aTrJ up to date policles In pla￿ to protect vulnerable FEople and other meM￿rS of the public ftDm unreasonable tehaviour. In 2023 no complaints atrKJut Wessex Can￿r SupFQrt fundraising prad1￿$ or attivities were received by the Fundraising Regulator. Trustees, responsibilities in relation to the financial statements The trustses (who are also directors of Wes*x Can￿r Supwrt for the purF¥Jses of company law) are resFonsible for preparing the trustees. report and the financlal statements in accordan￿ with applicable law and Un'tsd Kingdom Accounting Standards (United Klngdom Generally Accepted Accounting Pracbtr). Company law requires the trustees to prepare finanoal statements for each flnanclal year. Under company law the trustees must not approve the finanaal statements unless they are sat15f1￿ that they give a true and fair view of the stste of affairs of the charitsble company and the group and of the incomiThJ resources and application of resour￿, indLKling the inc(xne and expenditure, of the charitatle group for that period. In prepanng these financial statements, the trustees are require l* sultst4e accounting policie5 and then apply them consistentty; observe the methcxls and principles In the Charities SORP (FRS102); make judgments and accountlng estimates that a￿ reasonable and prudent,. state whether applicable UK Accountlng Stsndards have been followed, subject to any trb3terial departures disclosed and explained In the financial statements; Wesw Carcer gJptKJrt. Registered Company No: 05416311 Pa9e 22 of 47 Wessex Gincer Support Annual report and accounts for the year ended 31 December 2023 prepare the financial statements on the going concern basis Lmle55 It is inappropriate to presume that the chartsble group will continue in operation. The trustees are restx)nslble for keeping adequate accounting records that are sufficient to show and explain the charitable company and the group's transactions and disclose with reasonable accuracy at any time the Financial position of the charltable group and enable them to ensure that the financial ststements compw with the Ccffipanies Act 2006. They are also responsible for safeguarding the assets of the charitable company and the group and hen￿ for taking reasonable step5 for the prevention and detection of fraud and other irregularities. Provision of information to auditor Each of the pe￿OnS who are trustees at the time Wh￿ this trustees, reFQrt is approved has conflrmed that: so far as that trustee is aware, there is no relevant audit information of whth the charivs audrtors are unaware, and each trustee has taken all the steps that ought to have been tsken as a trustee in order to be aware of any information needed by the charity'5 auditors in connection with preparing their Fort and to establish that the charity's auditors are aware of that information. Auditor Azets Audit Services were aprKiinted auditors to the group and in accordan￿ with sertion 485 of the Companies Act 2006, a resolution proposing that they te re-appointed will be put at the Annual General Meeting. This report was approved by the trustees on 15105124 and signed on their tehalf by Diane Cutler air of Trustees Wesw Cancer SupFQrt. RoLstered cr￿p)nY No.. 05416311 Page ￿ of 47 Wessex Canc•r Support Independtht audltsrfs report to the trnstees of Wessex Cancer Support Independent auditor's report to the trustees of Wessex Cancer Support Opinion We have audited the finanaal statements of Wessex Cancer Support (the'charitable parent compan and its subsidiary (the'group) for the year ended 31 December 2023 whith comwise the Consolidated ststement of Financial Artivities, the Consolhdated Balan￿ Sheet, the Company Balan￿ sheet, the Consolidated Cash Flow Ststement and notes to the financial ststements, including a summary of signtficant a(rounting p)licies. The financial rerK)rting framework that has tEen applied in their prepardtion is applioble law and United Kingdom Ac(x)unting Standards, including Financial Reporting Stsndard 102'The Financial Reporting Stsndard applicable in the UK and Republic of Ireland. (United Kingdom Generally Actrpted Accounting PTrttice}. In our opinion, the financlal ststements: give a true and fair view of the state of the group's and of the charitsble parent companVs affairs as at 31 December 2023 and of the group's incornlng resources and application of resour￿5, including its income and expenditure, for the year then ended; have teen properly prepared in accordantr wfth United Kingdom Generally Accepted Accounting Practice; and have IEen prepared in accordan￿ wlth the rquirements of the Companies Act 2006. Basis for opinion We conducted our audit in accordan￿ with Intemational Standards on Auditing (UK) (ISAS (UK)) and applicable law. Our responsibilities under those staTrJards are further described in the Auditor's responsibilities the audit of the financial statements section of our reFOrt. We are indeFendent of the charity in accordance with the ethical requirements that are relevant to our audit of the financFal ststements in the UK, induding the FRCS Ethitsl Standard, and we have fulfilled our ot￿r ethical responsibilities in accordan￿ with these requI￿rnents. We believe that the audit eviden￿ we have obtained is sufficient and appropriate to provide a basis for our opinion. Conclusions relabng to going concem In auditing the finanaal statements, we have conduded that the trustees, use of the golng con￿rn basis of accounting in the preparation of the finanaal ststements is appropriate. Based on the work we have performed, we have not identified any material Un￿rtaIn￿"eS relating to events or condition5 that, individually or collettivelyi may cast significant doubt on the g￿up & charitable parent company's ability to continue as a ￿￿)1ng conttrn for a perioj of at least thefve months from when the financial statements a￿ authorised for issue. Our responsibilities and the responsibilities of the trustees wlth respect to going conom are desrri in the relevant sections of thi5 report. Wessex Cancer SuppLYt. Regl¥tered Company No.. 054163LI PagE 24 of47 W¢ssex Cancer Support Independent auditorfs rewt to the trusttt8 of Wessex Can￿r Support Other information The other information comprlses the information Includ￿ in the annual trustees, repjrt other than the financial staternents and our aUdit0￿S report thereon. The trustees a￿ resp)nsible for the other infomiation o)ntsined within the annual rewrt. Our opinion on the finanaal statsments does not cover the other infonnation, eX￿pt to the extent otherwlse explicitly ststed in our reporL and we do not exp￿5$ any form of assurance condusb)n thereon. Our resFonsibility is to read the other infonnation and, in doing so, consider whether the other infomiatr'on is materially inconsistent with the finantial ststements or our knowledge ¢Jbtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencie5 or apparent material misstatements, we are required to determine whether this gives rise to a material misststement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to re￿rt in this regard. Opinions on other matters prescribed by the Companies Act 2006 In our opinion, based on the work undertaken in the course of our audit: the Information given in the trustees, reFort, which iKludes the directors, report and the strateglc rekM)rt p￿pared for the purpose5 of company law, for the finandal year for which the financial statements are prepared is conskstent with the financial statements; and the Strategic report and the dlrectors, rerx)rt included within the trustees, report have been prepared in accordance with applicable legal requirements. Matters on which we are required to report by exception In the light of the knowl&Jge and understanding of the group and parent tharitable company and its environment obtsined in the course of the audit, we have not identifigj material misstatements in the strategic report or the directors, rewrt. We have nothing to report in respert of the following matter5 in relation to which the Companies Act 2006 repuires us to report to you if, in our opinion: adequate accounting reo)rds have not Ixen keFt by the paMt charitsble company, or returns adequate for our audit have not been re￿iVed from branthes not visited by us; or the parent chariL4ble company's finaniial statements are not in agreement with the accounting rerords and returns,. or certain disdosures of trustees, rernuneraticm specified by law are not made; or we have not received all the Information and explanations we require for our audit. Responsibilities of twstees As explained rn0￿ fully in the ststsment of trustees, responsibillyes, the trustees, who are also the directors of the charity for the purp)se of company law, are resFonsible for the preparation of the finanaal ststements and for being satisfied that they give a tjue and fair view, and for such internal Wessex CarKer Supwt. Registered Company No: 05416311 Page 25 of47 Wessex Cancér Support Independent audltorfs report to the trustees of Wessex Cancer support contrd as the trust￿ determine is necessary to enable the preparation of finanaal statements that are free from materlal misstatement, whether due to fraud or error. In preparing the financial ststements, the trustees are responsible for assessing the charity's ability to continue as a going con￿rn, disclosing, as applicable, matters rdated to golng con￿rn and using the going conom basis of accounting unless the trustees etther InteThJ to IKiuthte the charitable company or to cease operations, or have no realistic altemative but to do so Auditorfs responsibilities for the audit of the financial statements Our objectives are to obtsin reasonable assuran￿ about whether the finanaal ststements as a whole are free from material misststement, whether due to fral￿ or error, and to issue an aLwJitor's rewrt that includes our opinion. Reasonable assurance is a high level of assurance but is mt a guarBnt that an audit conducted in accordan￿ with ISAS (UK) will always detert a material misstatement when it exists. Misstatements can arlse from fraud or error and are considered material if, individually or in the aggregate, they could reasonably ￿ expected to influentr the eronomic deosions of users tsken on the basis of these finanaal statements. A further descrlption of our respjrsibilities is available on the Flnandal Reporting Counal's website at: h￿tt S.i'iwiiiw.frc.orci. uklauditorsi es onsibililies. Thi5 description forms part of auditorfs reFOrt. Extent to which the audit was considered capable of detecting irregularities, including fraud Irregularities, including frdud, are InStan￿S of non<0mplian￿ with laws and regulations. We design procedures in line with our responsibilities, outlined atove and on the Finanoal ReP￿ing Counal's website, to detect material mi55trdtements In res￿ of irregularitEs, induding fraud. We obtain and update our understsnding of the entlty, fts activities, its control environmenL and likely future developments, including in relation to the legal and regulatory framework applicable and how the entity Is complying with that framework. Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or er￿r, design and perform audit procedures ￿SponSive to those risks, and obtain audit eviden￿ that is suffioent and appropriate to provide a basis for our wnion. This indudes consideration of the risk of acts by the entity that were contrary to applicable laws and rejulations, induding fral￿￿. In response to the risk of irregularities and non-complian￿ with laws and regulations, induding fraud, we designed prccdures whid) induded., Enqulry of management and those charpj with governan￿ around actual and potential litigation and claims as well as actual, suspected and alleJed fraud; Reviewing minutes of m￿tIr￿S of those charged with governan￿. Assessing the extent of ￿MplianCe with the law5 and regulations consthred to have a direct material effett on the financial statements or the operations of the entity thr￿gh enquiry and inspection. Reviewing financial ststement disclosures and testing to supp￿ng dccumentstion to assess compliance with applicable law5 and regulations; Wts5ex ￿n￿r Sup5X)rt- Rwered Cryrpony No.. 05416311 Page 26 of47 Wessex Cancer Support Independent auditorf$ ryrt to the tNstees of Wessex Cancer Support Performing audit work over the risk of management bias and override of controls, induding testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions otjtside the nomial course of busine55 and reviewing accounb.ng estimates for indicators of potential bias. Because of the inherent limitations of an audi¢ there 15 a risk that we will not detc(t all irregularities, induding those leading to a material misstatement in the finanoal Statements or non-rr)mpliance regulation. This risk increases the more that Complian￿ with a law or regulation is removed from the events and transaLtions reffected in the financial statements, as we will te less likely to become aware of Instan￿ of non-ccsmpliance. The risk of not detecting a material misstatement resulting frorn fraud is hlgher than for one resulting from error, as frdud may involve colluslon, forgery, tentional omissions, misrepresentations, or the oveThide of internal contml. Use of our report This report is made solely to the charitable ccMnpanV5 members, as a tojyi In accordan￿ wlth chapter 3 part 16 of the Companies Act 2(I)6. Our audit woth has been undertaken so that we might state to the charitable company's meM￿rS those matters we are re]uired to state to them In an auditors, report and for no other pU￿oSe. To the fullest extent pemiitted by law, we do not a￿pt or assume responsibility to anyone other than the charitable company ané the charitable companvs members as a tody, for our audit worl for this report, or for the opinions we have fomied. Signed by ILAC Jon Noble, Senior Statutory Auditor For and on behalf of Azets Audit Services ststutory Auditor Athenia House 10-14 Andover Road Winchester Hampshire United Kingdom S023 7BS Date IS HI. 201 Wew Cancersupwrt. Reglstewj Ccfflpany No.. 05416311 Page 27 ef 47 Wessex Cancer Support Consolldated ststement of flnanclal artivities (indudlng income and expenditure account) for the year ended 31 December 2023 Consolidated statement of financial activities (including income and expenditure account) for the year ended 31 De￿mber 2023 Total Funds Trtal Funth Y￿rt0 Yewto 31-12-23 31-12-22 Fund5 Funds Furlds Income: 220305 562,934 95S,443 6.413 40.426 1,785,521 126.938 347,243 2,934 955,443 6,413 40fv26 1,912,459 827,054 844,0 333,591 i,426 2,543,018 Al￿ foF ?Lsln9 f**x invtsty￿t Inccrne 126,938 ExpÈndllure C4Xts of vduntary Income Costs of achMU•s for rJ151ng funds 326,561 463,0% 326,561 463,096 286000 404,154 Carè li li 747.161 9,303 137,623 213 324,038 501 1,206I22 10,017 1,909 45,748 1,546,121 137,836 324,539 2,C•)6, 1.708*11 N•tlna>rrR bofore n¢t (Ir￿50￿)19aITr5 on In¥4stm￿athd 239H(KI (137,836) 1197,6011 196,037) 834A07 Net 91lrsl(l%￿) on lbW8slm￿1* Taxatk)n Is 62,830 3,741 298,489 62030 3,741 (36,948) (i) (137,836) 1197,601) 831746 20121 15,752 137,836 1153,5881 1351,1891 Not movom•nt In funds for the Fund balanca ￿0￿ghtfOrW*4Id at 13•nuary 2023 314,241 (36,948) 832,746 1,19L,706 121)0,O 652,091 3,043,797 2.211)J51 1,$05,947 IRoo,ot 3tMI.902 3,CQ6049 3,043,797 The statement of financial attivities includes all galns and losses reccxJnised in the year. All incoming reSoUr￿S ￿$Our￿S exFended derive from continuing activlties. We5w Cancér Support- Re>5thd C￿￿panY No.. 05416311 Page 28 of 47 Wessex Cancer Support Consolldated statement of flnancial activities {induding income and expenditure account) for the year ended 31 December 2022 Consolidated statement of financial artivities (including income and expenditure account) for the year ended 31 De￿mber 2022 Total Funds Yearto 31-12-22 Funds Fund$ Funds Jn•V¢ns Legac*s Actfvlty•s fci ral￿r￿4 funds 15,3 827.OS4 838.881 333.591 3A26 2 018 342 519,539 534,929 827,OS4 644,018 333,591 3,426 18 5,137 524 76 Exp•nditw• Costs of r•lslng fvNIs: Costs of Mwng vdurtary Ints)mè 2e6,8L 404.154 288￿00 404,154 li li 694.350 277,559 971,909 277 59 1708 611 Nat Income bef(¥rt nrt Il%sesJlgakns on Iw•theDts ar*J tsx Net (lossesyylns un tnvestr*nts Taxoljon 587,290 (i) (1,6601 247.117 834.407 <1) (1,6601 15 585 29 247 117 T￿n￿lS 20121 (565.990) $90.$63 (24,573) Met mo¥ementln fund5 forth• y•ar Fund bolanrns brought forward at l January 2022 Fund bal•nw ¢*vled fornard at 31 D•c*mber 2022 19,639 63 222.S44 832,746 67 li 51 652 The statement of financlal attivit￿$ includes all gains and losses reccyjnised in the year. All incoming resources and resources expEnded derive from a)ntinulng activities. we￿ Carter Sw)p)rt. Regthred Company No.. 05416311 Page 29 of 47 Wessex c￿Tr￿r Support Consolidated and Charlty balance sheets as at 31 December 2023 Consolidated and Charity balance sheets as at 31 December 2023 Group Note 31-12-23 31-12-21 31-12-23 31-12-22 T•n9ible assgts 14 15 77,551 75,730 137 57,138 1461760 67,745 138 09 75 67 98 Current assets Debtors due %Yithin year Cash at bank and In hand 16 314,123 1,295,631 674,318 2,415,863 373,225 1,215,903 706,￿3 2,360,725 1,609,754 3,090,181 1,589,128 3J)67,708 Credltorn: amounts famlng due wlthln one year 17 122 si 1,470040 1967,930 1,487,951 2,975,914 3,010,149 3,043,797 3,IX16,849 3￿43,797 Cv•dltors: an￿Unts falling du8 after move than one year 18 3,300 3 043 797 06 Funds 20 21 21 3￿,902 1,2C*),OOD 1,505,947 652,091 1,200,01)0 1,191,706 300,902 1,200,000 1,505,947 652,091 1,200,000 1,191,706 The financial ststements on pages 28 to 47 were approved by the LN)ard of trustees on 15105124 and signed on their behalf by Martin Miles Wessex Cancer Suppcrt- RegiSt￿d Company fio.. 05416311 Page 30 of47 Wessex Gincer Support Consolldated statement of cash flows for the yeay ended 31 December 2023 Consolidated statement of cash flows for the year ended 31 December 2023 31-12-13 31-12-22 25 40,426 3.426 PurdRse of tsngible fixed assets 14 (31645) (22,357) 15 {1,398.7911 Cash (uged) by Imiesting ac*vltle• 91 io (Decraa8e)Iln(Yeate In cagh and c48h equlvalents in 32 428 181 Cath and cash eq￿valents at the b•glnnibVJ of the year 2.415M3 I,987.￿2 Total cash and ¢agh equfvakntsattha of the year 31 2 415 863 Cagh at bank L295.631 2,415,863 1 2415863 Statsment of changes in net debt- tsble loa SORP Analysls of changes In net debt At 01￿1-13 31.12-23 Cash at bank 4J5 1120 232 1295 631 1415863 (1,120,232) 1,295,631 Wessex Can￿r Support. Reglstered ffipany No.. 05416311 Page 31 of47 Wessex Cancer Support Notes fornilng part of the financial statements for the year ended 31 Deeember 2023 Notes forming part of the financial statements for the year ended 31 December 2023 I Principal accounting policies Basis of preparation The financial ststements have been prepared in accordance wlth Accounting and Reporting by Chaiitres." Ststement of ReCoMmer￿ed Practice appllcable to charitles preparing their accounts in accordance with the Firbancial Reporting SiarKlard applKable in the UK and Republic of Ireland (FRS 102) (effKtive l January 2019) (Charitie5 SORP (FRS102), the Financial Repjting Standard applicable In the UK and Republic of IrelaTrJ {FRS102) and the Companies Act 2006. The Charlty Is a public benefit entity as defined by FRSIO2. The fi￿nCIal statements are p￿pared under ￿ historical cost convention in sterling, whith is the functional currency of charty, as m¢)Jified by the indusion of investments at market value. Monetary anK)unts in these financial 5tstements are rounded to the nearest pound. No estimate used in the accounts will have a slgnificant risk of a material ￿ljustMent to the carrylr#J amounts of the assets & Ilabilitfies in the next financial year. Going concern At the time of approving the financial ststements. the trustees have a rea9Jnable eX￿￿￿tiOn that the Group has adequate resources to continue in operational existen￿ for the foreseeable future. Thus the accounts are prepared on a goirwJ concern basis. Group financial statements The statement of financial attivities and balan￿ sheet consolidate the financial ststements of the charity, and ts subsKliary undertakirKJ. The results of the subsidiary a￿ con501klated on a Ilne-by-line basis. A separate statement of financial activities and income and expendlture ￿Unt are Jv)t presented for the charity itself following the exempuons afforded by section 408 of the Companies Act 2006. The parent company's result for the financial year was a defKit of £37,561 (surplus for the year to 31 D￿ember 2022.. £705,601.) Charitsble funds Unrestricted funds are available for use at the dlscretion of the trustees In furtherarKe of the general obJ￿tIveS of the charlty and whith have not been designated for other purposes. Designat￿ funds have teen set aside by management for particukir operauonal and strateg purposes. Restricted funds are funds which are to be used in accordan￿ wlth sperific restricti￿$ imposed by donors cff which have been raised by the charity for particular purposes. The cost of ralslng admllllstering such funds are charged ￿aInSt the specific fund. The aim and use of each restricted fund is set out in the notes to the financial ststements. Wessex Canw Support. Re9￿t￿e￿ Company No.. 05416311 Paoe 32 of47 Wessex Cancer Support Notes forming part of the flnancial statements for the year ended 31 December 2023 Incoming resour DonatM)rs and artivits'es for generatlrvJ fuThJs are recognlsed in the per¥)d in whith trE charity receives the income or when there is a reasonable assuran￿ of receipt. Income Is defetT8J only when the charity has to fulfil conditions before becomiThJ entitled to It or where the donor has spectfEd that the income 15 to be expended in a future period. Legacies are included in the statement of financial activities on a receivable basis, being recognised at the point of ￿tifIcatIOn of grant of probate when the charty's interest can be measured or estimated with suffici￿t ￿lIabIl￿. Govemment grants Govemment grants are r￿nIS￿l at the falr value of the asset ￿1Ved or ￿e1Vable when the￿ Is reasonable assuran￿ that the grant conditions will be met and the grants will be recelv&J. A grant that Sp￿lfieS performance conditions is recognlsed In income when the performan condib'ons are meL Where a grant dces Mt speclfy performance condfcions it Is r￿niSed in income when the proceeds are received or receNable. A grant re￿iVed before the rectsjnition crtsria are satisfied is recc#Jnlsed as liability. Investments and investment income Investments hekl as fixed assets are stated at market value. Galns and losses on investments both reali5ed and unrealised are includ8J in the statement of financial activities. All income arising on investments is accounted for on a recelvable basls. Resources expended All resources experK1ed, IrKluding irrecoverable VAT, are charged against income on an accruals basis. Expenditure is allocated directly where the costs are direcdy attributable, otherwise on a ba515 of staff usage and thelr alk(ation of time. Tangible fixed assets and depreciation Tanglble fixed assets are stated at cost less depr￿latIOn. Depreclation Is provwjed on all tsngible r￿ed assets at rates cakukit8J to wr￿e off the cost less thelr estimated resldual value on a stra￿ht- line basis over their expthd useful econom￿ lfves as follows: LeaseFK4d Pr(4)&ty Motor Vehides Fixtures and Fittings over length of lease5 bel￿een IOO/o and 200/0 Fer annum btheen 15% and 330h per annum No asset under £500 is capitslised. wes￿ Can￿r kn￿rt. Regiaertd Company No.. OY16311 Page 33 of 47 Wessex Cancer Support Notes forniing part of the flnancial statements for the year ended 31 December 2023 Pensions The charity operates a group defined contrlbutlon pension scheme. Penslon cc6ts a￿ charg&J to the Statement of Financial Activities as incurred. Operdting leases Rental costs ￿￿ler operating leases are charged to the Statement of Financial Activitie5 a5 i￿Urr￿S over the pericd of the leases. 2 Legacies There is inherent uKertainty in the probate valuation of eststes as a result of the nature underlying assets and liabilities, the time that elapses between probate closure, and other contingenaes that attend the estate. Legacles are recognised at the point of notrfication of grant of probate when it can be measur&l or esti￿￿ted with suffKient reliability. A total amount of legacy income of £562,934 (2022.. £827,054) was recognised in the year, and a bala￿e of £238,147 (2022: £472,167) was incI￿led within debtors as at the year end. 3 Activities for raising funds Total 31-12-23 Funds Funds FurKlrèising everts and appeals Retsll Income (see noté 6) 387,975 567,468 955,443 387,975 567,468 955,443 Unrestrlcted Restrfcted Funds Funds Total 31-12-22 F￿￿raISIng events and appeals Retall Income (see note 6) 308,122 5,137 313,259 530 759 844,018 838,881 5,137 Wessex CanwSuppcrt- Registw& Company N¢.. 05416311 Page 34 of47 Wessex Cancer Support Notes forniing part of the financial statements for the year ended 31 December 2023 4 Other income Total 31-12-23 Funds Funds Govemment grants Insuran￿ dalms Lease surnxler 1,264 5,149 6,413 1,264 5,149 6,413 T•)tal 31-12-22 Funds Govemment gRnts Insur3r￿ dakns Leas• surrerKlar 2,903 19,202 311,486 333,S91 2,903 19,202 311,486 333,591 5 Investment income Total 31-12-23 2023 Funds Funds Income from ltstqd InveStM￿ts Bank Interest 40,425 40,426 40,426 Total 31-12-22 2022 Funds Funds Bank Interest 3,426 3,426 Wesw CarKer 9Jpport. Reglstered Company No: 05416311 Page 35 of47 Wessex Cancer Support Notes fomiing part of the financial statements lor the year ended 31 DeCeM￿r 2023 6 Income from trading activities of subsidiary The charity has a wholly owned tradlng subsKliary, Wessex Cancer Support TKading Limited, whlch is Ino)rporated in the UK, and whose prlncipal activity Is to cary on all of the trading activities f( Wessex Can￿r Suprort. Its trading results for the year, as extract￿ from ￿ audited financial statemerts, are summari below: Profft and Losg Account 31-12-13 31-12-21 Retsil income Cost of sales GM*s Profit 567.468 530,759 547.805 517.854 (443,433) (391,249) (Yther income Profft before taxation 105,636 128.805 Tax on proffts (3,741) (1,660) Profft for the fllwiri•l y￿r 101,895 127,145 Retained eaming brought forward Amount gift aided to the Tn Retainod profit (101,895) (127,145) We5fex CAnw Supp(¥t- Reglsiered Cryany No: 05416311 Pag¢ ￿ of47 Wessex Cancer Support Notes formlng part of the flnancial statements for tho year ended 31 December 2023 7 Total expenditure staff Costs De￿ecIatiOft Other Costs Total 31-12-23 2023 Cost of generatlng fvnd5 (Note 9) Provision of swykes (Note 11) Support costs (Nots 10) Govemance (Note 10) 400,137 471,440 216,649 30,950 1 119 176 10,794 378,726 306,578 159,219 13,973 858,496 789,657 778,018 395,898 20,030 2 008 496 2022 Stsff Costs Deweclatlon Other Costs Totsl 31-12-22 Cost of genpnting funds {Note 9) Provision of servlces (Note 11) Support costs (Note 10) Govemance (Note 10) 355,683 409,6T7 6,830 328,441 229,437 114,548 25,950 690,954 639,114 326,532 52,011 182,428 29,556 973￿9 36,386 698 376 1708,611 8 Net Incoming Resources for the Year TNS has been stated after charging.. 31-12-23 31-12-22 Opern￿n9 lease rentsls (Bulldings) Depreclatlon Athlltots remunwatlon Audlt Fee Other Servkes 243,235 30,824 219,219 36,386 17,443 210 14,080 920 Wessex Canor Support- RegIs￿red Company No: Q541￿11 Page 37 of 47 Wessex Cancer Support Notes formlng part of the financial statements for the year ended 31 December 2023 9 Cost of generdting funds Total 31-12-23 Funds Funds Voluntsry Income Fundfttslng siaff cost5 General fundraislng costs ChaFty organlsed event costs AdVe￿stng and publicity 185,537 36,424 65,895 38,705 326,561 185,537 36.424 65,895 38,705 326 61 Trading costs: 214,600 248,496 463 096 789,657 214,600 248,496 463,096 789,657 Other Unrestrlctrd Funds Restricted Funds Total 31-12-22 Voluntary Income Fundraising 5tsff costs General fundTrising costs Charity organised event costs Advertising and publiaty 158,217 35,548 64,979 158,217 35,548 64,979 286,800 286 800 Trading costs: Staff costs oth 197,466 206 688 197,466 404 154 690 954 690 954 w￿eX Can￿r Support. Re9L*ered Ccthpany Ntr.. 05416311 Page 38 ￿47 Wessex Cancer Support Notes forming part of the flnancial statements for the year ended 31 December 2023 10 Allocation of support and governance costs Charitable activities 5UPPOrt costs are fUrtI￿r analysed in note 11 and alkKated 98Qh (2022: 90iYo) Care and 20/0 (2022: 109/0) Education. Total 31-12-23 247,599 132.052 20,792 6.375 13.973 20,030 440,821 216,649 132,052 20,792 6,375 30,950 Tlme Usage Computer Costs Legal Fees Audit 13,973 20,030 395,898 Total 31-12-22 Basls of Support costs Governance Allo¢atlon staff Costs offi￿ Costs Computer Costs Legal Fees Audtt Depreciation 208,489 95￿34 16,278 2,436 25,950 29,556 378 543 182,428 95,834 16,278 2,436 26,061 Time Usaje Usage UwJe Usage Uwje 25,950 29,556 326 32 INesw Can￿r SLVFQrt. RegL#tred Ccrfnpany No.. 05416311 Paoe 39 of 47 Wessex Caftcer Support Notes forniing part of the flnanaal statement$ for the year eThd￿l 31 December 2023 I l Analysis of expenditure on charitable activities (nrte io) 31-12-23 Care Educatlon 776,817 1,201 778,018 387,980 7,918 395,898 44,025 898 44,923 1208,822 10,017 1,218,839 Total 31-12-23 Funds Funds Funds Counselllr¥J Complgmentsry therapy Health edu￿￿On 287,402 27,754 125,503 12,120 213 137,836 295,502 28,536 501 324,539 708,407 68,410 1,201 778,018 315,643 Support costs Governance (note io) Total 31-12-22 Care Educatlon 631,220 7,894 639,114 293,879 32,653 326,532 46,810 5,201 52,011 971,909 45,748 1,017,657 Unrestrfcted Deslgnated Re&Tkted Funds Funds Funds Total 31-12-22 Jnselllng Complementsry thernpy Health educatlon 344,545 12,544 4,466 361,555 264,501 9,630 3,428 277,559 609,046 22,174 7,894 639,114 We&8ex Canw Supwt. Registera Company No.. 05416311 Page 40 of47 Wessex Cancer Support Notes forniing part of the finanaal statements for the year ended 31 December 2023 12 Staff costs Total 31-12-23 Funds Funds 2023 Salwles Natlonal Insurance Penslon costs 898,528 71,353 18,653 988,534 119,615 8,715 2,312 130,642 1,018,143 80,068 20,965 1.119,176 Total 31-12-22 Fund$ FurMIs 2022 Salarfes Natlonal Insurance Penslen costs 725,3S4 58,569 161,305 10,422 886,659 68,991 799,480 174,370 973,850 One empbyee recefved remuneration btheen £80,000 and £90,000 per annum durlng 2023. In the pr￿r year, one employee received remuneratlon betjveen £70,Crf)O and £80,000. key management personnel of the group comprise5 the trusttt5, the chief executive, director of organisational effectiveness, dir¥tor of fundralsing and communications, dirthr of seNices, director of flna￿e and director of retsil. The totsl empbyee benefts of the key management personnel of the charity during the year were £316,313 (2022: £303,102). The average number of full-time equwalent empbyee5 duriTrJ the peri¢)d was 33 (2022.. 30). Pension costs outstanding at the year-end were £3,268 (2022: £3,295). RedundanLy payments totslling Énil were made durlng the year (2022.. £nil). The tharty also acknowl&Jges the help of part time volunteers on both a regular basls and ad hoc basls, without whKh Wessex Can￿r Support could not operate effectlvely. 13 Trustees, remuneration and expenses No trustee recefved ary remuneration during the year (2022.. £nil). One trustee received reimbursement of £208 (2022: £54) for travel expen*. We5￿ Canw Support- Reglstered Crynp4ny No.. 05416311 Page 41 of 47 Wessex Cancer Support Notes f0rn7ing part of the financial statements for the year ended 31 December 2023 14 Tangible fixed assets Group tangible fixed assets Leasehold Motor Flxturns & propeity vohldes flttlngs Totsl At l January 2023 Addltions Diswsals At 31 D￿rnber 2023 320,644 25,650 107,208 30.985 453,502 32,645 Depredatlon At l January 2023 Charge for the wiod Disp)sals At 31 De￿mber 2023 275,017 9,849 24.076 1,573 78.679 19,402 377,772 30.824 284,866 98.081 408,596 Ilet book value At 31 De￿rnber 2023 At 31 December 2022 Charity tangible ftsed assets Tolal pn)p* ¥ehldes fltlings At l January 2023 Additions Disposals At 31 December 2023 188,352 25,649 83,290 16,335 297,291 16,335 At l January 2023 iJ)arge for the period Disposals At 31 December 2023 150,705 6,912 24,076 1,573 54,765 18,457 229,546 26,942 157 617 25 22 Net book value At 31 December 2023 At 31 December 2022 37 647 ￿73 28 525 Wes*% Carttr 9Jpp)rt. Registered Company No: 05416311 Page 42 of47 Wessex Cancer Support Notes fornilng part of the financlal statements for the year ended 31 De￿rnber 2023 15 Fixed asset investments 31-12-11 31-12-22 31-12-23 31-12-22 Flxed asset investments at Ma￿et value: Invesknent portfolio at l January 2023 Additior6 at cost Dividends receib Net investment gainsl(l(w) 136 1,398,791 137 138 1,398.791 137 62 830 1461758 136 136 Historical Cort vestrnent ￿thI10 at at 31 Dec&nber 2023 ￿98 791 It9 1398 791 119 Subsidiary company: The charity owns 2 ordinary shares of £1 representing 100% of the issued share capital of Wessex Can￿r SupFort Trading limited. Group Chaitty 31-12-23 31-12-22 31-1>23 31-12-22 Portfolio indudes: Sarasin ErKio7MMent Fund Class A Liquld Assets 51 Lhyds Bankirfj Gr￿aP Icp ￿dInary shar 1,200,820 260.914 1.200,820 260,914 24 1.461.758 114 24 138 114 24 138 1,461.758 16 Debtors Group 31-1>22 Charlty 31-12-23 31-12-22 31-12-23 Amounts falling du• wlthln one year Trnde debtors PreFayments and acawl Inc¢)me ades acuued Amounts due from sulxldljry 0th8r debtors 11,348 52,861 238,147 6,628 188,957 472,167 11,348 28,208 238,147 88,063 7,459 373,225 6,628 145,685 472,167 77,412 5,091 706,983 11,767 314,123 6,566 674,318 We55e< Can￿r &wwJrt. Regi*red Corpany No.. OY163LI Page 43 of 47 Wessex Cancer Support Notes forniing part of the financial statements for the year ended 31 December 2023 17 Creditors: amounts falling due within one year Group 31-12-23 31-12-22 31-12-23 31-12-22 49,278 34,528 SS,108 138,914 33,034 60045 28,772 122,251 38,493 21224 40,460 101,177 25,817 42,093 23,884 91,794 Acuuals and deferrad Incomè other uedltors 18 Credttors: amounts falling due after more than one year Charlty 31-12-23 31-12-22 31-12-23 31-12-22 3,300 3.300 19 Financial commitments At 31 ￿ern￿r the followiro commitments were held under nOn-Ca￿ellab1e property feases: Group 31-12-23 31-12-22 Charfty 31-12-23 31-12-22 Under i year Btheen 2 to S years S years 211,904 222,595 129,4D7 222,932 90,067 56,000 127,224 434 499 363 778 218 728 We55ex Cl￿r S4)p)rt- Rrf15tered Ccfflpany No.. 054163LI Pa9e 44 of47 Wessex Cancer Support Notss forniing part of the financlal statements fty the year ended 31 December 2023 20 Restricted funds (Group & Charity) Balance 1-1-23 Movement In resourw Transfers (d) Balan Incomlng Outgolng 31-12-23 (a) Centrès (b) Patlent ￿nSport (c) thJtr&ich programmes Total restrfthd funds 506,961 101,131 25,807 (221,537) (153,588) (8,932) 94,070 (324,539) (153,588) 232,967 21,881 46,0 300,902 140,124 652,091 126,938 Balance 1-1-22 M(wement In resources Transfers (d) Balance Incomlng Oirtgolng 31-12-22 (a) Centres (b) Pauent transpcrt (c) OLthxh programmes T¢*al restrIC￿ funds 405,790 23,757 314,676 10,000 200,000 (209,744) (7,939) 59,876 277,559 (3,761) (20,812) 506,961 S,006 140,124 652,091 429,547 24,573 (a)Specific funding for our centres whlch provsde emouonal ￿1th arKi wdlbelng support tD people wlth can￿r thelr loved ones. Supw>rt serv5￿ provided In centre5 ifKlude Wriendiro, counselling, (x)mplementsry therapies and exercise dasses. {b)Tr Southampton Portsmouth mlnlbus funding 5UPW)rts a pattent transport Se￿￿. (c) As part of our three-year strdtegy, we launched an outreath programme to eynd our reach. {d)Transfers: In 2023, £140,124 of the £153.588 relates to reda$slI￿ng Centre5' irKr)me that had b*n Incorrecuy shown as restrlcted income In 2022, plus transfers after the completion of a Lymphoedema cllnlc In 2022. In 2022, £20,812 relates to redasslfying transt)ort contratt Income shown incorredy as restricted funds, plus the balan￿ due to IOW capttal refurtyshment projert that was finished in 2021. Wessex Canw Support. Rtytstered COM￿)Y Nu., 05416311 Page 45 ￿47 Wessex Cancer Support Notss forniing part of the financlal statements for the year ended 31 December 2023 21 Statement of funds Balance 1-1-23 In rasources Inveslmènts Trangfws Balanc• Incomlng Oibtgolng movements 31-12-23 652,091 126 24 39 153 300,902 Unrestrkted funds Deslgnated Unrnstrk*ad fvnd9 1200.000 1,191.706 2.391,706 (137￿) 137,836 IS.752 153,S88 I200,￿0 1.505.917 2,705,%7 1,785,521 1,785,521 62 30 62030 1.687.698 3.043.797 1,912h59 (2,0122371 62A30 3,006A49 Balan¢• knment In v•souYces 1-1-22 Investments Trnnsfert Balance 31-12-22 T•)tsl yestrtrt￿ fvnds 429,547 524 76 652ml Deslgnat 609.437 1.172,067 1.781,504 590,S63 1,200.riJo 1,191,706 2.391706 2,018,342 2 016 342 1432 713 24,573 1710,272 3 043,797 De￿gnated funds have been set aside by the charlty out of vnrestrlcted legacles received durlng the year, to enable the chgdty to develop, improve and expand its reath range of seNKes as part of the strat8Jlc plan. 22 Analysis of net assets of the Groups funds Tan9lbl• Total x•d Asséts Inves￿ (Llabllltlas) 31.12.23 2023 ReStrk￿ funds Unrestrfcted funds DesIgnat￿ Funds 1,2to,oc 2617S8 1200.CQO 77 $1 1461758 Wessex Cancer Supp)rt- Re9lstereJ c￿P3nY No.. 05416311 Page 46 of47 Wessex Cancer Support Notes forming part of the flnanclal statements for the year ended 31 December 2023 22.. Analysis of net assets of the Group's funds - continued Tatholbl Total A95ets InTMStments (Llablllues) 31-12.22 2022 137 l)esigty*ed Funds 1200,000 1183 721 I.2(￿￿)0 I L91706 Z 391706 8S 85 137 2 967 930 3 043 797 23 Related party transactions There were no related paty transactions in the year (2022: £nil). 24 Taxation As a charlty, Wessex car￿er Support Is exempt from Corporatlon Tax on wofits applied to charitable rAJrposes, under Section 505 of the Income and Corporation Taxes Art 1988. The trddirvJ company uses the glft ald scheme to transfer an element of its proflts to the charity. In 2023 the tradlng (ompany distributed its tsxable profits to the charity of £101,895 (2022: £127.145) under the gift ald sd)&ne. In the current year the subsdiary has a deferred tsx liabillty of £3,741 (2022.. £1,660). or ttThs, £3,300 ￿lateS to 2023 and £HI to tsx on 2022 profits. 25 Reconciliation of net movement in funds to net cash flow from operating artivities 31-12-23 31-12-22 Net movement in funds Add back depreciation charge Dedurt investment intome recogni￿ in the statement of financial activities Add back unrealised (gain)Iloss on invesknents Decreasel {inC￿a$e) In debtors Increase in creditors Net cash inflow from operating activities (36,948) 30,824 832,746 36,386 (40,426) (62,830) 360,195 (3,426) (426,169) 270 778 26 Post balance sheet events There have been no Fost balan￿ sheet ev￿ts. Wessex SupFQrt. Reglstwed cOm￿nY Nty. 05416311 Page 47 of 47